Nawa Lodin is an associate in the firm’s Business Law Department and a member of its Technology and Life Sciences groups.

Ms. Lodin represents clients in a full range of corporate transactions and compliance matters. She focuses her practice on healthcare law and provides advice on a wide variety of state and federal laws and regulations including:

  • The Health Insurance Portability and Accountability Act (HIPAA)
  • Medicare and Medicaid fraud and abuse laws
    • Stark Law
    • Anti-kickback statute
  • Medicare and Medicaid program requirements
  • The Emergency Medical Treatment & Labor Act (EMTALA)
  • Federal Food, Drug and Cosmetic Act (FD&C Act)

Ms. Lodin handles a range of health care matters including advising start-ups, drafting and negotiating clinical trial agreements, managed care contracting, scope of licensure and governance issues, medical staff issues, telemedicine matters, providing health care compliance plans and training, and handling corporate transactions such as mergers and acquisitions, joint ventures and affiliations. Ms. Lodin also has experience with preparing Emergency Use Authorizations to the Food and Drug Administration (FDA) during public health emergencies, including during the COVID-19 outbreak. 

Ms. Lodin is fluent in speaking Dari.

Areas of Practice
Domaines D’Expertise





Ms. Lodin’s recent experience includes representation of:

  • dscout, a leader in experience research, enabling the world's most innovative companies to unlock human insight at scale, in its Series C financing round and tender offer to GGE Discovery Investor LP, a fund affiliated with Guidepost. 
  • PointClickCare Corp. in its acquisition of our client, Audacious Inquiry, a national industry-shaping health IT company that provides a connected care platform facilitating the secure transmission of actionable, accurate, and event-driven data across the U.S. healthcare system.
  • Capable Health, a software company that provides a platform that empowers developers and product teams to build healthcare apps centered around the patient, on its Series Seed-1 Preferred Stock financing.
  • Entrada Therapeutics, a biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines, Endosomal Escape Vehicles (EEV™), to engage intracellular targets, in its upsized initial public offering.
  • Icon Ventures in its Series C Preferred Stock investment in Fuzzy Pet Health, a provider of in home vet care for customers’ pets.
  • Marlin Equity Partners in its acquisition of Imagine Software, a revenue cycle management automation software for high-volume, complex medical billing.
  • Primus Capital Partners in their acquisitions of CORL Technologies, a provider of tech-enabled managed services for vendor risk management and compliance, and Meditology Services, a provider of information risk management, cybersecurity, privacy, and regulatory compliance consulting services exclusively for healthcare organizations.
  • Medical Properties Trust in its acquisition of Springstone, a leading provider of behavioral health services in the United States distinguished by its purpose-built, inpatient facilities in carefully selected markets across the full behavioral care acuity spectrum. 
  • OM1, a leading real-world outcomes and technology company leveraging big clinical data and AI to better understand, compare, and predict patient outcomes, in its Series D Preferred Stock Financing. 
  • Olink, a company dedicated to accelerating proteomics together with the scientific community, across multiple disease areas to enable new discoveries and improve the lives of patients, in its follow-on offering. 
  • Elligo Health Research in its acquisition of Root Health, an AI virtual assistant for clinical research. 
  • RxRevu, a developer of a prescription intelligence platform designed to manage and measure clinician's prescribing performance, in its Series C Preferred Stock financing. 
  • Vincere Health, a developer of a monitoring device designed to help to cut down or quit smoking or vaping, in its Series Seed Preferred Stock financing. 
  • ArchiveSocial, Inc., a portfolio company of Level Equity, in its acquisition of NextRequest Co., a developer of a record request platform designed to empower organizations to collaborate remotely. 
  • Level Equity Growth Partners IV, L.P. in its Series B financing of Sunwave Health, an SaaS company providing a comprehensive platform for behavioral health providers.
  • Sequoia Capital Heritage Fund in its Series F Preferred Stock of Lyra Health, a leading provider of innovative mental health benefits. 
  • JMI Equity in its acquisition of Timely Telehealth, student-focused telehealth platform company.
  • Tapestry, a family office private equity firm, in its acquisition of Danta Health Limited Liability Company d/b/a Vital Interaction, a healthcare software provider based in Austin, TX and specializes in automating complex communication workflows.
  • ZOLL Medical Corporation, an Asahi Kasei company, in its acquisition of Respicardia, Inc., a provider of novel implantable neurostimulators for the treatment of moderate to severe central sleep apnea.
  • True Ventures in its Series Seed Preferred Stock financing of MedZero, a mobile lending platform and employer benefit that enables employees to pay out-of-pocket medical bills without high credit card interest or 401K loan fees. 
  • Med-Data, a portfolio company of Frazier Healthcare Partners, in its acquisition of RevClaims, a provider of high-quality revenue cycle management services to hospitals and health systems.
  • SV Health Investors in its acquisition of Health Payment Systems, a privately-held healthcare technology and services organization.
  • Sword Health Technologies, a digital musculoskeletal therapy provider in its Series B Preferred Stock financing.
  •, a software company that provides a cloud-based data analytics, in its acquisition by Atlassian, Inc.
Professional Activities

Ms. Lodin is passionate about improving life for children in Afghanistan. She serves as Chair of the Associate Board of Women for Afghan Women (WAW), the largest non-governmental Afghan women's rights organization in the world.

Ms. Lodin is also a member of the ABA, NYSBA and NYSBA Health Law Section.

Professional Experience

Prior to joining Goodwin, Ms. Lodin was a health law associate at a national Am Law 100 firm in New York.

She also worked as assistant regulatory counsel for a national association which represents and advocates for ambulatory surgery centers. Ms. Lodin also worked as a senior compliance associate for a Washington, D.C.- based health care consulting firm.

While in law school, she worked as a law clerk in the Washington, D.C. office of a Mid-Atlantic law firm and as a legal staff assistant in the U.S. Department of Justice, Office of Human Rights and Special Prosecutions.

In The News









J.D., 2016
American University, Washington College of Law
B.A., 2013
The George Washington University



New York





Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique